CARLSMED, INC. (CARL) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US14280C1053
CARLSMED, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 50.51 m USD |
| Gross profit | 38.04 m USD |
| Operating income | -30.57 m USD |
| EBIT | -30.90 m USD |
| Net income | -29.63 m USD |
| Diluted EPS – continuing operations | -2.12 USD |
Full history since 2023, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About CARLSMED, INC.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
More stocks
- BizConf Telecom Co Ltd (300578.SZ)
- Changzhou Langbo Seal Polytron Technologies Co Ltd Class A (603655.SS)
- IEI Integration Corp (3022.TW)
- TECSYS Inc. (TCS.TO)
- Shanghai Xuerong Bio-Technology Co Ltd (300511.SZ)
- Anhui Zhongyuan New Materials Co Ltd (603527.SS)
- VALUE LINE INC (VALU)
- Pubang Landscape Architecture Co Ltd (002663.SZ)
- Jiangsu Jingxue Insulation (301010.SZ)
- Skymoons Technology Inc. (033790.KQ)
- GOLD RESERVE LTD (GDRZF)
- Shanxi Guoxin Energy Co Ltd B (900913.SS)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.